146 related articles for article (PubMed ID: 34481969)
1. HIV viral load suppression following intensive adherence counseling among people living with HIV on treatment at military-managed health facilities in Uganda.
Kikaire B; Ssemanda M; Asiimwe A; Nakanwagi M; Rwegyema T; Seruwagi G; Lawoko S; Asiimwe E; Wamundu C; Musinguzi A; Lugada E; Turesson E; Laverentz M; Bwayo D
Int J Infect Dis; 2021 Nov; 112():45-51. PubMed ID: 34481969
[TBL] [Abstract][Full Text] [Related]
2. Viral load suppression after intensive adherence counselling among adult people living with HIV at Kiswa health centre, Kampala: a retrospective cohort study. Secondary data analysis.
Nakaye C; Mukiza N; Mawanda D; Kataike H; Kaganzi H; Ahimbisibwe GM; Businge GB; Kyambadde RC; Nakalega R
AIDS Res Ther; 2023 Mar; 20(1):18. PubMed ID: 36998004
[TBL] [Abstract][Full Text] [Related]
3. Low HIV viral suppression rates following the intensive adherence counseling (IAC) program for children and adolescents with viral failure in public health facilities in Uganda.
Nasuuna E; Kigozi J; Babirye L; Muganzi A; Sewankambo NK; Nakanjako D
BMC Public Health; 2018 Aug; 18(1):1048. PubMed ID: 30134880
[TBL] [Abstract][Full Text] [Related]
4. Unsuppressed viral load after intensive adherence counselling in rural eastern Uganda; a case of Kamuli district, Uganda.
Ndikabona G; Alege JB; Kirirabwa NS; Kimuli D
BMC Public Health; 2021 Dec; 21(1):2294. PubMed ID: 34922502
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of intensive adherence counselling in achieving an undetectable viral load among people on antiretroviral therapy with low-level viraemia in Uganda.
Nanyeenya N; Nakanjako D; Makumbi F; Nakigozi G; Nalugoda F; Kigozi G; Nasuuna E; Kibira SPS; Nabadda S; Kiyaga C; Huzaifah M; Kiwanuka N
HIV Med; 2024 Feb; 25(2):245-253. PubMed ID: 37853605
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for unsuppressed viral load after intensive adherence counseling among HIV infected persons in Kampala, Uganda: a nested case-control study.
Izudi J; Castelnuovo B; King R; Cattamanchi A
AIDS Res Ther; 2023 Dec; 20(1):90. PubMed ID: 38110982
[TBL] [Abstract][Full Text] [Related]
7. Linkage to intensive adherence counselling among HIV-positive persons on ART with detectable viral load in Gomba district, rural Uganda.
Nakalega R; Mukiza N; Debem H; Kiwanuka G; Kakumba RM; Menge R; Kagimu IK; Nakaye C; Babirye JA; Kaganzi H; Lukyamuzi Z; Kizito S; Kuteesa CN; Mujugira A
AIDS Res Ther; 2021 Apr; 18(1):15. PubMed ID: 33879190
[TBL] [Abstract][Full Text] [Related]
8. High viral suppression rates among PLHIV on dolutegravir who had an initial episode of viral non-suppression in Uganda September 2020-July 2021.
Namayanja GA; Da Silva JF; Elur B; Nasirumbi PM; Raizes E; Ssempiira J; Nazziwa E; Nabukenya M; Sewanyana I; Balaba J; Ntale J; Calnan J; Birabwa E; Akao J; Mwangi C; Naluguza M; Ahimbisibwe A; Katureebe C; Nabadda S; Nelson L; Dirlikov E
PLoS One; 2024; 19(6):e0305129. PubMed ID: 38923981
[TBL] [Abstract][Full Text] [Related]
9. Barriers and facilitators to viral load suppression among people living with HIV following intensive adherence counseling in Kampala, Uganda: A qualitative study.
Izudi J; Cattamanchi A; Castelnuovo B; King R
Soc Sci Med; 2024 Feb; 343():116595. PubMed ID: 38242033
[TBL] [Abstract][Full Text] [Related]
10. Effect and implementation experience of intensive adherence counseling in a public HIV care center in Uganda: a mixed-methods study.
Lukyamuzi Z; Etajak S; Katairo T; Mukunya D; Tetui M; Ssenyonjo A; Wanyenze RK
BMC Infect Dis; 2021 Nov; 21(1):1168. PubMed ID: 34798852
[TBL] [Abstract][Full Text] [Related]
11. Enhanced adherence counselling and viral load suppression in HIV seropositive patients with an initial high viral load in Harare, Zimbabwe: Operational issues.
Bvochora T; Satyanarayana S; Takarinda KC; Bara H; Chonzi P; Komtenza B; Duri C; Apollo T
PLoS One; 2019; 14(2):e0211326. PubMed ID: 30721229
[TBL] [Abstract][Full Text] [Related]
12. Lack of effectiveness of adherence counselling in reversing virological failure among patients on long-term antiretroviral therapy in rural Uganda.
Birungi J; Cui Z; Okoboi S; Kapaata A; Munderi P; Mukajjanga C; Nanfuka M; Nyonyintono MS; Kim J; Zhu J; Kaleebu P; Moore DM
HIV Med; 2020 Jan; 21(1):21-29. PubMed ID: 31432614
[TBL] [Abstract][Full Text] [Related]
13. Impact of intensive adherence counseling on viral load suppression and mortality among people living with HIV in Kampala, Uganda: A regression discontinuity design.
Izudi J; Castelnuovo B; King R; Cattamanchi A
PLOS Glob Public Health; 2023; 3(8):e0002240. PubMed ID: 37549128
[TBL] [Abstract][Full Text] [Related]
14. Influence of intensified adherence counselling on viral load suppression of people receiving antiretroviral therapy at a health centre IV in southwestern Uganda: a qualitative study.
Pius A; Josephine NN; Erick S; Winifred A; Rita M; Silverjoseph O; Lucy E; Novatus N
AIDS Res Ther; 2021 Jul; 18(1):45. PubMed ID: 34321025
[TBL] [Abstract][Full Text] [Related]
15. Adherence to viral load testing guidelines, barriers, and associated factors among persons living with HIV on ART in Southwestern Uganda: a mixed-methods study.
Lubega P; Nalugya SJ; Kimuli AN; Twinokusiima M; Khasalamwa M; Kyomugisa R; Kabami J; Owaraganise A
BMC Public Health; 2022 Jun; 22(1):1268. PubMed ID: 35768800
[TBL] [Abstract][Full Text] [Related]
16. Challenges faced by caregivers of virally non-suppressed children on the intensive adherence counselling program in Uganda: a qualitative study.
Nasuuna E; Kigozi J; Muwanguzi PA; Babirye J; Kiwala L; Muganzi A; Sewankambo N; Nakanjako D
BMC Health Serv Res; 2019 Mar; 19(1):150. PubMed ID: 30845951
[TBL] [Abstract][Full Text] [Related]
17. Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018.
Mhlanga TT; Jacobs BKM; Decroo T; Govere E; Bara H; Chonzi P; Sithole N; Apollo T; Van Damme W; Rusakaniko S; Lynen L; Makurumidze R
AIDS Res Ther; 2022 Jul; 19(1):34. PubMed ID: 35810317
[TBL] [Abstract][Full Text] [Related]
18. The association between low-level viraemia and subsequent viral non-suppression among people living with HIV/AIDS on antiretroviral therapy in Uganda.
Nanyeenya N; Chang LW; Kiwanuka N; Nasuuna E; Nakanjako D; Nakigozi G; Kibira SPS; Nabadda S; Kiyaga C; Makumbi F
PLoS One; 2023; 18(1):e0279479. PubMed ID: 36638086
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of viral load suppression, predictors of virological failure and patterns of HIV drug resistance after 12 and 48 months on first-line antiretroviral therapy: a national cross-sectional survey in Uganda.
Ssemwanga D; Asio J; Watera C; Nannyonjo M; Nassolo F; Lunkuse S; Salazar-Gonzalez JF; Salazar MG; Sanyu G; Lutalo T; Kabuga U; Ssewanyana I; Namatovu F; Namayanja G; Namale A; Raizes E; Kaggwa M; Namuwenge N; Kirungi W; Katongole-Mbidde E; Kaleebu P;
J Antimicrob Chemother; 2020 May; 75(5):1280-1289. PubMed ID: 32025714
[TBL] [Abstract][Full Text] [Related]
20. Long-term virologic responses to antiretroviral therapy among HIV-positive patients entering adherence clubs in Khayelitsha, Cape Town, South Africa: a longitudinal analysis.
Kehoe K; Boulle A; Tsondai PR; Euvrard J; Davies MA; Cornell M
J Int AIDS Soc; 2020 May; 23(5):e25476. PubMed ID: 32406983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
